Legal & General Group
NAUT icon

Legal & General Group’s Nautilus Biotechnolgy NAUT Stock Holding History

Legal & General Group’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.06K Buy
+4,844
New +$12.8K ﹤0.01% 3325
2025
Q2 		– Sell
-4,148
Closed -$3.57K – 3491
2025
Q1 		$3.57K Hold
4,148
– – ﹤0.01% 3319
2024
Q4 		$6.97K Hold
4,148
– – ﹤0.01% 3304
2024
Q3 		$11.8K Hold
4,148
– – ﹤0.01% 3242
2024
Q2 		$9.71K Hold
4,148
– – ﹤0.01% 3301
2024
Q1 		$12.2K Hold
4,148
– – ﹤0.01% 3157
2023
Q4 		$12.5K Sell
4,148
-687
-14% -$1.97K ﹤0.01% 3193
2023
Q3 		$15.3K Hold
4,835
– – ﹤0.01% 3134
2023
Q2 		$18.7K Buy
4,835
+815
+20% +$2.35K ﹤0.01% 3133
2023
Q1 		$11.1K Hold
4,020
– – ﹤0.01% 3190
2022
Q4 		$7.24K Hold
4,020
– – ﹤0.01% 3312
2022
Q3 		$9K Hold
4,020
– – ﹤0.01% 3354
2022
Q2 		$11K Buy
+4,020
New +$15K ﹤0.01% 3363

Other funds holding NAUT

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Legal & General Group's NAUT Position: Q2 2026 in Review

Legal & General Group opened a new position in Nautilus Biotechnolgy (NAUT) in Q2 2026: 4,844 shares worth $9.06K. The stake represents ﹤0.01% of the portfolio and ranks #3325 among its holdings. This is a return to the name: Legal & General Group previously reported a position in NAUT as recently as Q1 2025.

Legal & General Group first reported a position in NAUT in Q2 2022 and has held it in 13 quarters since. The position peaked at $18.7K in Q2 2023. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • Legal & General Group held 4,844 shares of Nautilus Biotechnolgy worth $9.06K as of Q2 2026.
  • Nautilus Biotechnolgy was a new Legal & General Group position in Q2 2026.
  • Nautilus Biotechnolgy made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #3325 holding.
  • Legal & General Group first reported a position in Nautilus Biotechnolgy in Q2 2022 and has held it in 13 quarters since.
  • Legal & General Group's Nautilus Biotechnolgy position peaked at $18.7K in Q2 2023.
  • 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.